巨噬细胞移动抑制因子在强直性脊柱炎中诱导炎症并预测脊柱进展
研究纳入符合改良纽约标准的强直性脊柱炎(AS)患者,以健康志愿者、类风湿关节炎和骨关节炎患者为对照,发现AS患者基线血清MIF水平显著升高且可独立预测AS进展;MIF在滑液中升高,肠道产MIF巨噬细胞和Paneth细胞富集,并能诱导单核细胞产生TNF、激活成骨细胞β-catenin并促进矿化。
要点
- AS患者基线血清MIF水平显著高于健康对照,且可独立预测AS脊柱进展。
- AS患者滑液MIF水平更高,肠道产MIF巨噬细胞和Paneth细胞富集。
- MIF诱导单核细胞产生TNF、激活成骨细胞β-catenin并促进矿化。
核心结论
- MIF在AS中具有尚未被探索的致病作用,并连接炎症与新骨形成。
研究设计与样本
- 研究招募符合改良纽约标准的AS患者,并以健康志愿者、类风湿关节炎患者和骨关节炎患者作为对照。
- 根据改良Stoke AS脊柱评分(mSASSS)年增长率将AS患者分为进展者与非进展者。
- 采用酶联免疫吸附试验定量血清和滑液MIF水平,用逻辑回归分析评估AS进展预测因素。
- 对回肠组织进行免疫组化分析以识别产MIF细胞,用流式细胞术识别产MIF亚群、MIF受体(CD74)表达模式及MIF诱导的外周血TNF产生。
- 用茜素红S染色分析MIF诱导的成骨细胞(SaOS-2)矿化,用Western blotting定量活性β-catenin水平。
主要发现
- AS患者基线血清MIF水平较健康对照显著升高,且可独立预测AS进展。
- AS患者滑液中MIF水平更高,其肠道中产MIF巨噬细胞和Paneth细胞富集。
- MIF诱导单核细胞产生TNF,激活成骨细胞中的β-catenin,并促进成骨细胞矿化。
临床怎么用
- 基线血清MIF水平可能作为预测AS脊柱进展的候选生物标志物。
- MIF通路可能成为连接AS炎症与新骨形成的潜在治疗靶点。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To investigate the role of macrophage migration inhibitory factor (MIF) in the pathogenesis of ankylosing spondylitis (AS). METHODS: Patients who met the modified New York criteria for AS were recruited for the study. Healthy volunteers, rheumatoid arthritis patients, and osteoarthritis patients were included as controls. Based on the annual rate of increase in modified Stoke AS Spine Score (mSASSS), AS patients were classified as progressors or nonprogressors. MIF levels in serum and synovial fluid were quantitated by enzyme-linked immunosorbent assay. Predictors of AS progression were evaluated using logistic regression analysis. Immunohistochemical analysis of ileal tissue was performed to identify MIF-producing cells. Flow cytometry was used to identify MIF-producing subsets, expression patterns of the MIF receptor (CD74), and MIF-induced tumor necrosis factor (TNF) production in the peripheral blood. MIF-induced mineralization of osteoblast cells (SaOS-2) was analyzed by alizarin red S staining, and Western blotting was used to quantify active β-catenin levels. RESULTS: Baseline serum MIF levels were significantly elevated in AS patients compared to healthy controls and were found to independently predict AS progression. MIF levels were higher in the synovial fluid of AS patients, and MIF-producing macrophages and Paneth cells were enriched in their gut. MIF induced TNF production in monocytes, activated β-catenin in osteoblasts, and promoted the mineralization of osteoblasts. CONCLUSION: Our findings indicate an unexplored pathogenic role of MIF in AS and a link between inflammation and new bone formation.
引用
- Ranganathan V, Ciccia F, Zeng F, et al. Macrophage Migration Inhibitory Factor Induces Inflammation and Predicts Spinal Progression in Ankylosing Spondylitis. Arthritis Rheumatol. 2017. PMID: 28597514. doi:10.1002/art.40175
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。